Literature DB >> 2476393

Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis.

T F Murphy1, L C Bartos.   

Abstract

The outer membrane proteins (OMPs) of Branhamella catarrhalis were studied in an effort to identify surface-exposed determinants that are conserved among strains of the bacterium. Aliquots of polyclonal antiserum were absorbed individually by strains of B. catarrhalis. The absorbed antisera were tested in comparison with unabsorbed antiserum in an immunoblot assay against OMPs of the homologous strain. The absence of a band recognized by antibodies in the absorbed antiserum compared with the unabsorbed antiserum indicated that surface-exposed determinants of the absorbing strain cross-reacted with determinants on the homologous strain. Two antisera were absorbed individually by 20 strains of B. catarrhalis, and the absorbed sera were studied in this way in immunoblot assays. OMP E (molecular weight, ca. 56,000) expresses surface-exposed determinants that are shared among 17 of the 20 strains studied. Antibodies to OMP G (molecular weight, 28,000) were absorbed from both antisera by 14 of the 20 strains. These studies demonstrate that OMP E and OMP G express determinants that are exposed on the surface of the intact bacterium. Furthermore, these determinants are antigenically conserved among a majority of strains of B. catarrhalis. On the basis of these observations, OMPs E and G should be considered when bacterial antigens are evaluated as potential vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476393      PMCID: PMC260751          DOI: 10.1128/iai.57.10.2938-2941.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Cephalexin monohydrate suspension. Treatment of otitis media.

Authors:  S E McLinn; J F Daly; J E Jones
Journal:  JAMA       Date:  1975-10-13       Impact factor: 56.272

2.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

3.  Branhamella (Neisseria) catarrhalis--a lower respiratory tract pathogen?

Authors:  M A Johnson; W L Drew; M Roberts
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

4.  Isolation of the outer membrane of Branhamella catarrhalis.

Authors:  T F Murphy; M R Loeb
Journal:  Microb Pathog       Date:  1989-03       Impact factor: 3.738

5.  Immunoblot method for identifying surface components, determining their cross-reactivity, and investigating cell topology: results with Haemophilus influenzae type b.

Authors:  M R Loeb
Journal:  Anal Biochem       Date:  1984-11-15       Impact factor: 3.365

6.  Isolation of Branhamella catarrhalis from sputum and tracheal aspirate.

Authors:  J M Aitken; P E Thornley
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

7.  Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.

Authors:  N J Slevin; J Aitken; P E Thornley
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

8.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

Authors:  P A Shurin; C D Marchant; C H Kim; G F Van Hare; C E Johnson; M A Tutihasi; L J Knapp
Journal:  Pediatr Infect Dis       Date:  1983 Jan-Feb

9.  Development of bactericidal antibody during Branhamella catarrhalis infection.

Authors:  A J Chapman; D M Musher; S Jonsson; J E Clarridge; R J Wallace
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods.

Authors:  J Luotonen; E Herva; P Karma; M Timonen; M Leinonen; P H Mäkelä
Journal:  Scand J Infect Dis       Date:  1981
View more
  40 in total

1.  Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis.

Authors:  T F Murphy; C Kirkham; E DeNardin; S Sethi
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Serum antibody response to outer membrane proteins of Moraxella (Branhamella) catarrhalis in patients with bronchopulmonary infection.

Authors:  J J Christensen; N Q Hansen; B Bruun
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

3.  Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis.

Authors:  S Sethi; J M Surface; T F Murphy
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Reptiles as a source of Salmonella O48--clinically important bacteria for children: the relationship between resistance to normal cord serum and outer membrane protein patterns.

Authors:  Gabriela Bugla-Płoskońska; Agnieszka Korzeniowska-Kowal; Katarzyna Guz-Regner
Journal:  Microb Ecol       Date:  2010-05-18       Impact factor: 4.552

5.  Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis.

Authors:  R Bhushan; R Craigie; T F Murphy
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

6.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection.

Authors:  M Rahman; T Holme; I Jönsson; A Krook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

8.  Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.

Authors:  Ryka Moore; Jennelle M Kyd; Rosemary Carzino; Davide Armstrong; Keith Grimwood; Diana C Otczyk; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

9.  Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay.

Authors:  M E Helminen; R Beach; I Maciver; G Jarosik; E J Hansen; M Leinonen
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

10.  Serum antibody response to proteins of Moraxella (Branhamella) catarrhalis in patients with lower respiratory tract infection.

Authors:  J J Christensen; J Renneberg; B Bruun; A Forsgren
Journal:  Clin Diagn Lab Immunol       Date:  1995-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.